looking beyond jak inhibitors: novel targeted therapies and strategies for mpn treatment
Published 3 years ago • 234 plays • Length 3:21Download video MP4
Download video MP3
Similar videos
-
1:47
moving beyond jak inhibitors: novel targets and pathways being explored for the treatment of mpns
-
1:23
targeted therapies beyond jak inhibitors
-
1:11
session sneak peek: where to place novel jak inhibitors
-
1:26
the future of jak inhibition for mpns
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
49:17
atacicept; a novel inhibitor of baff and april in development for the treatment of igan
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
3:23
myelofibrosis: updates on jak inhibitors
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
3:35
considering the key benefits of each jak inhibitor approved for the treatment of mpns
-
3:51
novel agents in mzl: btkis, pi3k inhibitors, and immunotherapeutics
-
2:23
expert views on the changing landscape in ra: the increasing role of jak inhibitors
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
3:48
jak inhibition for the early treatment of myelofibrosis
-
1:07
advancements in combination strategies with jak inhibitors for myelofibrosis
-
4:16
jak inhibitor selection & sequencing in myelofibrosis
-
20:42
beyond jak2 inhibitors: new targets and new agents
-
2:23
factors to consider when selecting jak inhibitors for patients with mf
-
0:46
xport-mf-034: selinexor plus ruxolitinib in jak-inhibitor naïve myelofibrosis